Post-operative inflammatory and angiogenic response in patients with resectable colon cancer: a randomised clinical trial comparing open versus laparoscopic surgery

ISRCTN ISRCTN55624793
DOI https://doi.org/10.1186/ISRCTN55624793
Secondary identifying numbers 001
Submission date
02/07/2009
Registration date
19/08/2009
Last edited
27/01/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Miguel Pera
Scientific

Colorectal Surgery Unit
Department of Surgery
Hospital del Mar
Passeig Marítim 25 - 29
Barcelona
08003
Spain

Phone +34 93 24 83 207
Email mpera@imas.imim.es

Study information

Study designRandomised controlled two-arm trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleRandomised clinical trial of the inflammatory and angiogenic responses of open and laparoscopic surgery for colon cancer
Study acronymARALOS
Study objectivesThe increased inflammatory response in patients with colon cancer undergoing open resection compared with laparoscopic surgery is associated with an increased angiogenic response.
Ethics approval(s)Hospital del Mar Comité Ético de Investigación Clínica (IRB) approved in June 2003 (reference number 2003/1621/I)
Health condition(s) or problem(s) studiedColon cancer
InterventionPatients are randomised to either laparoscopic or open colectomy. Serum and peritoneal fluid samples are obtained at baseline, 12, 24 and 48 hours and post-operative day 4. Peritoneal fluid samples are obtained through an aspirative drain.
Intervention typeOther
Primary outcome measure1. Post-operative vascular endothelial growth factor (VEGF) serum and peritoneal fluid levels
2. Post-operative platelet derived growth factor (PDGF) serum and peritoneal fluid levels
3. Microvascular density determined in serum and peritoneal fluid on in vitro angiogenesis assay
4. Capillary length determined in serum and peritoneal fluid on in vitro angiogenesis assay

Samples obtained at baseline, 12, 24 and 48 hours and post-operative day 4.
Secondary outcome measures1. Levels of pro-inflammatory cytokines interleukin-6 (IL-6) and interleukin-1 beta (IL-1 beta) determined in serum and peritoneal fluid
2. Correlation between pro-inflammatory and angiogenic cytokines

Samples obtained at baseline, 12, 24 and 48 hours and post-operative day 4.
Overall study start date01/06/2004
Completion date31/12/2007

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants120
Key inclusion criteria1. Patients with resectable colon cancer, either sex
2. Written informed consent
3. Aged older than 18 years
Key exclusion criteria1. Patients with metastasic disease
2. Patients with locally advanced colon cancer
3. Patients undergoing emergency surgery
4. Transverse colon and splenic flexure cancer
5. Patients with a second neoplasm
Date of first enrolment01/06/2004
Date of final enrolment31/12/2007

Locations

Countries of recruitment

  • Spain

Study participating centre

Colorectal Surgery Unit
Barcelona
08003
Spain

Sponsor information

Hospital del Mar (Spain)
Hospital/treatment centre

Passeig Maritim 25 - 29
Barcelona
08003
Spain

Phone +34 63 97 64 484
Email mpera@imas.imim.es
Website http://www.hospitaldelmar.cat
ROR logo "ROR" https://ror.org/03a8gac78

Funders

Funder type

Government

Spanish Ministry of Health, Investigation of Sanitary Funding (Fondo de Investivación Sanitaria Ministerio de Sanidad y Consumo) (Spain)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/01/2011 Yes No